1. Home
  2. SKYE vs JRSH Comparison

SKYE vs JRSH Comparison

Compare SKYE & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.93

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$2.94

Market Cap

37.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYE
JRSH
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
37.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SKYE
JRSH
Price
$0.93
$2.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$14.75
$4.00
AVG Volume (30 Days)
263.7K
91.2K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
6.71%
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$146,234,005.00
Revenue This Year
N/A
$11.71
Revenue Next Year
N/A
$7.69
P/E Ratio
N/A
$60.06
Revenue Growth
N/A
12.25
52 Week Low
$0.99
$2.81
52 Week High
$5.75
$4.17

Technical Indicators

Market Signals
Indicator
SKYE
JRSH
Relative Strength Index (RSI) 31.94 31.88
Support Level $1.04 $3.02
Resistance Level $1.27 $3.07
Average True Range (ATR) 0.10 0.09
MACD 0.00 -0.01
Stochastic Oscillator 4.55 0.00

Price Performance

Historical Comparison
SKYE
JRSH

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: